Genital Warts
📧 Sign up to get email alerts when something new happens for Genital Warts.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-02-04Clinical Trial Update: HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts [NA]
A completed clinical trial investigating whether physician reminders and recommendation scripts improve HPV vaccination uptake; results were…
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: The Role of Genital Warts in HIV Acquisition in Peru
This completed clinical trial examined whether genital warts influence HIV acquisition risk among participants in Peru.
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001) [Phase 2]
Phase 2 study of a broad-spectrum HPV vaccine (V505-001) in women aged 16-26 has completed; the trial evaluated the vaccine's potential to p…
-
CLINICAL_TRIALS trial_result · 2015-08-21Clinical Trial Update: Safety Evaluation of a Human Papillomavirus (HPV) Vaccine in Healthy Female Control Subjects From the GSK HPV 023 Study [Phase 3]
Phase 3 safety evaluation update from the GSK HPV 023 study showing safety results for an HPV vaccine in healthy female control subjects; re…
-
FDA approval · 2015-07-06FDA Approved: VEREGEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for VEREGEN (sinecatechins) submitted by ANI Pharmaceuticals, under NDA 021902.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-06-16Clinical Trial Update: Immunevasion of Human Papillomavirus (HPV) in Vulvar Intraepithelial Neoplasia 2/3 and Anogenital Warts and Efficiency and Mechanisms of Imiquimod Treatment [Phase 2]
Phase 2 clinical trial evaluating imiquimod for HPV-related vulvar intraepithelial neoplasia (VIN 2/3) and anogenital warts has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED) [Phase 2]
Completed Phase 2 trial evaluating tolerability and immunogenicity of the V504 HPV vaccine candidate when administered with GARDASIL for HPV…
-
CLINICAL_TRIALS trial_result · 2015-04-10Clinical Trial Update: A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine [Phase 3]
This completed Phase 3 trial evaluated the immunogenicity of a proposed paediatric dosing schedule for the human papillomavirus (HPV) vaccin…
-
CLINICAL_TRIALS trial_result · 2015-03-12Clinical Trial Update: Giving Immunizations Through Vaccine Education [NA]
A clinical trial update about immunization education for HPV vaccines; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2015-03-12Clinical Trial Update: Recurrent and Nonrecurrent Condyloma Treatment [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating a treatment for recurrent and nonrecurrent genital warts (condyloma acuminatum) has been termina…
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003) [Phase 3]
Phase 3 trial update for a multivalent HPV vaccine in 16- to 26-year-olds showing completion and posted results.
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: Two-dose Schedule of Quadrivalent HPV Recombinant Vaccine in 11-year-old Boys in Mexico City [Phase 3]
An update on a Phase 3 trial evaluating a two-dose schedule of the quadrivalent HPV recombinant vaccine in 11-year-old boys in Mexico City.
-
CLINICAL_TRIALS trial_result · 2014-12-22Clinical Trial Update: A Study of the Safety, Tolerability, and Immunogenicity of a 9-valent Human Papillomavirus Vaccine ([9vHPV]; V503) Administered to 9- to 15-Year-Old Japanese Girls (V503-008). [Phase 3]
A phase 3 trial assessing safety, tolerability, and immunogenicity of 9-valent HPV vaccine (V503) in Japanese girls aged 9-15; trial complet…
-
CLINICAL_TRIALS trial_result · 2014-12-22Clinical Trial Update: A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006) [Phase 3]
Phase 3 trial update for V503 (9-valent HPV vaccine) in females 12-26 who previously received GARDASIL; study completed with results posted …
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001) [Phase 3]
A Phase 3 clinical trial update on a broad-spectrum HPV vaccine study in women aged 16-26 has completed enrollment and posted results in 201…
-
CLINICAL_TRIALS trial_result · 2014-10-31Clinical Trial Update: Alternate Dosing Schedules Study for HPV Vaccine (ADS)
A completed clinical trial update for the Alternate Dosing Schedules Study for the HPV vaccine (ADS) sponsored by Duke University, evaluatin…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Alternate Dosing Schedules Study for HPV Vaccine [Phase 4]
Phase 4 trial evaluating alternate dosing schedules for an HPV vaccine; results completed and posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-04-22Clinical Trial Update: SR-T100 Gel Efficacy & Safety Study for Vulva Pre-cancerous Lesions & Cutaneous Condyloma [EARLY_Phase 1]
A completed early-phase 1 trial evaluating the efficacy and safety of SR-T100 Gel for vulvar intraepithelial neoplasia and genital warts.
-
CLINICAL_TRIALS trial_result · 2014-02-26Clinical Trial Update: Randomized Trial of Alternative HPV Vaccination Schedules in Males in a University Setting [NA]
Completed randomized trial evaluating alternative vaccination schedules for the quadrivalent HPV vaccine in males; results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2013-12-02Clinical Trial Update: Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series [NA]
This completed clinical trial tested a tool designed to increase completion of the HPV vaccine series (Gardasil). Results were posted in Dec…
-
CLINICAL_TRIALS trial_result · 2013-08-14Clinical Trial Update: Human Papilloma Virus (HPV) Vaccination Among Rural African American Primary Caregivers and Daughters
A completed clinical trial update examining HPV vaccination among rural African American primary caregivers and their daughters.
-
CLINICAL_TRIALS trial_result · 2013-03-18Clinical Trial Update: Effectiveness Study of Gardasil on Condyloma
Completed clinical trial assessing Gardasil's effectiveness against genital warts (condyloma).
-
FDA approval · 2013-03-01FDA Approved: VEREGEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Veregen (sinecatechin) submitted by ANI Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2013-01-15Clinical Trial Update: Typing of Human Papilloma Virus (HPV) From Female Genital Warts
This clinical trial update reports HPV typing results from samples taken in female genital warts; the trial is completed and results were po…
-
CLINICAL_TRIALS research · 2012-03-20Clinical Trial Update: Human Papillomavirus (HPV) Genotypes in Genital Warts in Colombian Population
This completed clinical trial study investigates HPV genotypes present in genital warts in the Colombian population.